Clinical Trials Browser

Phase 1 × Interventional × Antibodies, Monoclonal × Clear all

Neoplasms

NCT04120246 2024-07-10

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Phase 1 Suspended

24 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04315467 2022-06-16

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Phase 1 Completed

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02546284 2020-02-28

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Phase 1 Completed

15 enrolled

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic

NCT02350712 2018-09-11

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

Phase 1 Completed

15 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT03631836 2018-08-17

MARELLE01

Phase 1 Unknown

34 enrolled

CNS

Glioblastoma

NCT00356460 2014-03-19

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Phase 1 Completed

29 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT00052403 2014-01-16

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00956436 2013-09-16

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Phase 1 Completed

40 enrolled

Gastrointestinal

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Phase 1 Suspended

95 enrolled

LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

A Study of BND-35 in Participants With Advanced Solid Tumors

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

MARELLE01

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma